Locations
Ulm, Germany · Baden-Württemberg, Germany
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series A
founded in
2015
NVision Imaging Technologies GmbH is pioneering the use of metabolic magnetic resonance imaging (MRI) by leveraging advances in quantum physics. Their unique platform transforms standard MRIs into powerful metabolic imagers, enabling early assessment of patient responses to cancer treatment at the cellular level. The company's flagship product, POLARIS, offers rapid and precise measurement of natural metabolites, facilitating non-invasive diagnostics across various medical fields including oncology, cardiology, and neurology. With a focus on high throughput and ease of use, NVision is positioned to disrupt the medical imaging landscape, providing critical insights for adaptive cancer treatment and improving patient outcomes.
Something looks off?On-site & Remote